Barry Gause
Overview
Explore the profile of Barry Gause including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu W, Luke B, Wu X, Lee J, Yi Y, Okpechi S, et al.
JNCI Cancer Spectr
. 2024 Sep;
8(5).
PMID: 39270065
Background: The consequence of diabetes on lung cancer overall survival (OS) is debated. This retrospective study used 2 large lung cancer databases to assess comprehensively diabetes effects on lung cancer...
2.
Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu S, et al.
Haematologica
. 2011 Nov;
97(4):586-94.
PMID: 22102710
Background: MicroRNAs can play an important role in tumorigenesis through post-transcriptional regulation of gene expression, and are not well characterized in follicular lymphoma. Design And Methods: MicroRNA profiles of enriched...
3.
Brohl A, Song J, Lieberman R, Gause B
Am J Ther
. 2011 Oct;
20(5):549-53.
PMID: 22020085
We report the case of a 65-year-old man who presented with epigastric pain and guaic-positive stool. Upper and lower endoscopy revealed abnormalities in the gastric antrum and terminal ileum. Biopsy...
4.
Rahma O, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin V, et al.
J Transl Med
. 2010 Jan;
8:8.
PMID: 20109232
Background: Due to the lack of specific tumor antigens, the majority of tested cancer vaccines for renal cell carcinoma (RCC) are based on tumor cell lysate. The identification of the...
5.
Toubaji A, Achtar M, Provenzano M, Herrin V, Behrens R, Hamilton M, et al.
Cancer Immunol Immunother
. 2008 Feb;
57(9):1413-20.
PMID: 18297281
Introduction: There is mounting evidence describing the immunosuppressive role of bulky metastatic disease, thus countering the therapeutic effects of tumor vaccine. Therefore, adjuvant immunotherapy may have a better impact on...
6.
OMahony D, Morris J, Quinn C, Gao W, Wilson W, Gause B, et al.
Clin Cancer Res
. 2007 Feb;
13(3):958-64.
PMID: 17289891
Purpose: Eleven patients with progressive advanced malignancy after administration of a cancer vaccine received a fully human anti-CTLA-4 monoclonal antibody (ipilimumab). The primary end point was to determine drug toxicity....